ARTICLE
- U.S.
(2020)
Merck & Co Inc , which has largely kept to the sidelines of the race for COVID-19 treatments, said it was buying Austrian vaccine maker Themis Bioscience and would collaborate with research nonprofit IAVI to develop two separate vaccines.
Visibility: Public (all visitors)
Comments
Related Chunks
Related chunks with this resource
A collection of articles about Drug Research and the Pharma industry
a collection of articles about Merck Pharmaceutical company - and their treatment, vaccine development for COVID19 Coronavirus
No comments yet. Be the first to comment!